Guillaume Bouguen
Toulouse, 31300, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 174 publications
Methotrexate for inflammatory bowel disease: the MICI-METHO multicenter retrospective cohort study.
Journal: Journal of Crohn's & colitis
Published: July 22, 2026
Real world experience with granulocyte and monocyte adsorptive apheresis (ADACOLUMN®) in patients with refractory inflammatory bowel disease: a retrospective observational multicenter cohort study.
Journal: Clinics and research in hepatology and gastroenterology
Published: May 28, 2026
Cystic fibrosis-associated inflammatory bowel disease: a case series and literature review.
Journal: Clinics and research in hepatology and gastroenterology
Published: February 26, 2026
Sex Differences in Treatment Expectations, Satisfaction and Tolerance After Switching to CT-P17, an Adalimumab Biosimilar: A Post Hoc Analysis of the YU-MATTER Study.
Journal: Rheumatology and therapy
Published: January 23, 2026
Artificial Intelligence Versus Conventional Scoring for Assessing Small Bowel Capsule Endoscopy Cleanliness in Crohn's Disease.
Journal: United European gastroenterology journal
Published: November 30, 2025
Diagnosis and management of patients with Crohn's disease. Position paper from the GETAID.
Journal: Clinics and research in hepatology and gastroenterology
Published: October 27, 2025
Update on IBD management: What's new in acute severe UC? - Modern management of perianal disease.
Journal: Clinics and research in hepatology and gastroenterology
Published: October 27, 2025
Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.
Journal: United European gastroenterology journal
Published: October 19, 2025
Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.
Journal: United European gastroenterology journal
Published: October 19, 2025
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID.
Journal: Journal of Crohn's & colitis
Published: September 10, 2025
Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label study.
Journal: Journal of Crohn's & colitis
Published: August 25, 2025
Last Updated: 09/26/2026